CHICAGO--(BUSINESS WIRE)--TVT2019 – Structural Heart Summit --Materialise (NASDAQ:MTLS), a global 3D printing software and solutions company, has received FDA clearance for its Mimics Enlight ...
Stratasys PolyJet technology and Materialise FDA-cleared software now most versatile 3D printing system for hospitals and physicians to build anatomical models at the point-of-care MINNEAPOLIS & ...
Charles R. Goulding and Andressa Bonafe show why starting small, investing in people, and following clinical demand are the real drivers behind successful hospital-based 3D printing programs.
Materialise, a 3D printing company with a focus on patient-specific parts, has received FDA clearance for its Mimics Enlight cardiovascular planning software suite. The product’s initial application ...
A video accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=27613 Materialise MTLS, a pioneer in 3D Printing for medical ...
Further bringing 3D printed medical models to life, Stratasys is expanding the suite of printers and materials validated by its collaborator Materialise as part of FDA-cleared Materialise Mimics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results